3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
5
Uterine Cervical Neoplasms
2
Rectal Neoplasms
2
Neoplasms
2
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Prostatic Neoplasms
1
Prostate Cancer, Hereditary, 7
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Muscle Weakness
1
Lung Neoplasms
1
Liver Neoplasms
1
Kidney Neoplasms
1
Hypoxia
1
Glioma
1
Glioblastoma
1
Gastrointestinal Neoplasms
1
Disease
1
Colonic Neoplasms
1
Astrocytoma
1
Anus Neoplasms
1
Interventions
Cyclophosphamide
8
Mycophenolic Acid
6
Whole-Body Irradiation
5
Busulfan
5
fludarabine phosphate
4
fludarabine
4
Tacrolimus
4
Cyclosporine
4
Rituximab
3
Etoposide
3
Cytarabine
3
venetoclax
2
ruxolitinib
2
pegfilgrastim
2
blinatumomab
2
asciminib
2
Prednisone
2
Peripheral Blood Stem Cell Transplantation
2
Methotrexate
2
Inotuzumab Ozogamicin
2
Filgrastim
2
tocilizumab
1
ricolinostat
1
rasburicase
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor, human
1
nilotinib
1
idelalisib
1
ibrutinib
1
ceralasertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia
×
Magnetic Resonance Imaging
×
30 days
×
Clear all
No trials found.